Open
SectorHealthcare
5.23 0.58
24h
Min
5.13
Max
5.28
Income | 2.9M 5.9M |
---|---|
Sales | 6.4M 52M |
P/E Sector Avg | 5.081 37.257 |
Profit margin | 11.166 |
Employees | 172 |
EBITDA | 6.8M 11M |
Recommendations | Sell |
---|---|
12 Months Forecast | -42.08% downside |
Next Earnings | 6 lis 2025 |
---|
Market Cap | 100M 258M |
---|---|
Previous open | 4.65 |
Previous close | 5.23 |
By Acuity
50%
50%
183 / 371 Ranking in Healthcare
By Trading Central
Confidence
Weak Bullish Evidence
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
Price change
By TipRanks
12 Months Forecast
Average 3 USD -42.08%
High 4 USD
Low 2 USD
Based on 2 Wall Street analysts offering 12 month price targets forPuma Biotechnology Inc - Dist in the last 3 months.
By Acuity
News Sentiment
Neutral
Volatility
Below average
News Volume (RCV)
Below average
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$